Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients-Reference-Cited by-同舟云学术

Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients

Published:2011-09-07 Issue:11 Volume:66 Page:2605-2614
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:Journal of Antimicrobial Chemotherapy

Author:

Neukam K.,Mira J. A.,Ruiz-Morales J.,Rivero A.,Collado A.,Torres-Cornejo A.,Merino D.,de los Santos-Gil I.,Macias J.,Gonzalez-Serrano M.,Camacho A.,Parra-Garcia G.,Pineda J. A.,Rivero-Juarez A.,Perez-Camacho I.,Torre-Cisneros J.,Aliaga-Jimenez A.,Lopez-Cortes L.,Palacios-Munoz R.,Santos-Gonzalez J.,Marquez-Solero M.,Nuno-Alvarez E.,Fernandez A.,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/66/11/2605/2249292/dkr357.pdf

Reference24 articles.

1. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy

2. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy

3. Drug-Induced Liver Injury Associated with HIV Medications

4. Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C

5. Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Efficient Humanized Mouse Model for Oral Anti-Retroviral Administration;Cells;2023-03-28

2. The Potential of Moringa oleifera to Ameliorate HAART-Induced Pathophysiological Complications;Cells;2022-09-24

3. NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved;Cells;2021-07-04

4. Combination of Tenofovir and Emtricitabine with Efavirenz Does Not Moderate Inhibitory Effect of Efavirenz on Mitochondrial Function and Cholesterol Biosynthesis in Human T Lymphoblastoid Cell Line;Antimicrobial Agents and Chemotherapy;2018-09

5. Combination of tenofovir and emtricitabine with efavirenz does not moderate inhibitory effect of efavirenz on mitochondrial function and cholesterol biosynthesis in human T lymphoblastoid cell line;2018-04-07